Archford Capital Strategies’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Sell
688,742
-352,698
-34% -$1.1M 0.22% 94
2026
Q1
$3.04M Buy
1,041,440
+98,387
+10% +$281K 0.35% 71
2025
Q4
$2.33M Buy
943,053
+9,902
+1% +$23.6K 0.27% 82
2025
Q3
$2.08M Buy
+933,151
New +$2.13M 0.25% 94
2019
Q3
Sell
-543
Closed -$3K 213
2019
Q2
$3K Buy
+543
New +$2.43K ﹤0.01% 494
2015
Q4
Sell
-4,344
Closed -$21K 850
2015
Q3
$21K Hold
4,344
0.02% 268
2015
Q2
$26K Hold
4,344
0.02% 243
2015
Q1
$25K Hold
4,344
0.02% 267
2014
Q4
$27K Buy
4,344
+935
+27% +$5.91K 0.02% 261
2014
Q3
$22K Hold
3,409
0.02% 285
2014
Q2
$24K Hold
3,409
0.02% 293
2014
Q1
$25.3K Buy
+3,409
New +$23.9K 0.02% 293

Other funds holding ABEV

Archford Capital Strategies's ABEV Position: Q2 2026 in Review

Archford Capital Strategies reduced its Ambev (ABEV) stake by 34% in Q2 2026, selling an estimated $1.1M and leaving 688,742 shares worth $2.16M. The position accounts for 0.22% of the portfolio, ranked #94.

Archford Capital Strategies first reported a position in ABEV in Q1 2014 and has held it in 12 quarters since. The position peaked at $3.04M in Q1 2026. 97 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Archford Capital Strategies held 688,742 shares of Ambev worth $2.16M as of Q2 2026.
  • Archford Capital Strategies sold 352,698 Ambev shares in Q2 2026, an estimated $1.1M.
  • Ambev made up 0.22% of Archford Capital Strategies's portfolio in Q2 2026, its #94 holding.
  • Archford Capital Strategies first reported a position in Ambev in Q1 2014 and has held it in 12 quarters since.
  • Archford Capital Strategies's Ambev position peaked at $3.04M in Q1 2026.
  • 97 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.